Jeffrey H. Margolis - Oct 16, 2023 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Role
Director
Signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for Jeffrey H. Margolis
Stock symbol
ALHC
Transactions as of
Oct 16, 2023
Transactions value $
-$48,016
Form type
4
Date filed
10/18/2023, 05:00 PM
Previous filing
Aug 23, 2023
Next filing
Nov 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALHC Common Stock Sale -$48K -6K -1.41% $8.00 420K Oct 16, 2023 See Footnote F1, F2, F3
holding ALHC Common Stock 74.5K Oct 16, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
F2 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $8.00 to $8.07. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
F3 Represents securities held by the Margolis Family trust 12/23/98, of which Mr. Margolis is the trustee.